SurgePays (SURG) Competitors $1.38 +0.07 (+5.34%) Closing price 04:00 PM EasternExtended Trading$2.70 +1.32 (+95.29%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock SURG vs. TELA, HYPR, ZYXI, LUCD, FONR, EDAP, ICCM, NSPR, SRTS, and NTRBShould you be buying SurgePays stock or one of its competitors? The main competitors of SurgePays include TELA Bio (TELA), Hyperfine (HYPR), Zynex (ZYXI), Lucid Diagnostics (LUCD), FONAR (FONR), Edap Tms (EDAP), IceCure Medical (ICCM), InspireMD (NSPR), Sensus Healthcare (SRTS), and Nutriband (NTRB). These companies are all part of the "medical equipment" industry. SurgePays vs. TELA Bio Hyperfine Zynex Lucid Diagnostics FONAR Edap Tms IceCure Medical InspireMD Sensus Healthcare Nutriband SurgePays (NASDAQ:SURG) and TELA Bio (NASDAQ:TELA) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Is SURG or TELA more profitable? SurgePays has a net margin of -27.39% compared to TELA Bio's net margin of -60.49%. SurgePays' return on equity of -55.63% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets SurgePays-27.39% -55.63% -43.61% TELA Bio -60.49%-556.18%-63.13% Does the MarketBeat Community believe in SURG or TELA? SurgePays received 110 more outperform votes than TELA Bio when rated by MarketBeat users. However, 74.07% of users gave TELA Bio an outperform vote while only 69.11% of users gave SurgePays an outperform vote. CompanyUnderperformOutperformSurgePaysOutperform Votes17069.11% Underperform Votes7630.89% TELA BioOutperform Votes6074.07% Underperform Votes2125.93% Do institutionals & insiders hold more shares of SURG or TELA? 6.9% of SurgePays shares are held by institutional investors. Comparatively, 94.3% of TELA Bio shares are held by institutional investors. 29.4% of SurgePays shares are held by company insiders. Comparatively, 6.0% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, SURG or TELA? SurgePays has a beta of 1.03, suggesting that its share price is 3% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500. Do analysts recommend SURG or TELA? SurgePays presently has a consensus price target of $8.50, indicating a potential upside of 515.94%. TELA Bio has a consensus price target of $7.25, indicating a potential upside of 484.68%. Given SurgePays' stronger consensus rating and higher probable upside, research analysts plainly believe SurgePays is more favorable than TELA Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SurgePays 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00TELA Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has higher valuation & earnings, SURG or TELA? SurgePays has higher revenue and earnings than TELA Bio. SurgePays is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurgePays$83.60M0.33$20.62M-$1.13-1.22TELA Bio$69.30M0.70-$46.66M-$1.39-0.89 Does the media favor SURG or TELA? In the previous week, TELA Bio had 23 more articles in the media than SurgePays. MarketBeat recorded 27 mentions for TELA Bio and 4 mentions for SurgePays. TELA Bio's average media sentiment score of 0.25 beat SurgePays' score of 0.00 indicating that TELA Bio is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SurgePays 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TELA Bio 5 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 7 Negative mention(s) 1 Very Negative mention(s) Neutral SummarySurgePays beats TELA Bio on 10 of the 18 factors compared between the two stocks. Remove Ads Get SurgePays News Delivered to You Automatically Sign up to receive the latest news and ratings for SURG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SURG vs. The Competition Export to ExcelMetricSurgePaysTelephone communication, except radio IndustryComputer SectorNASDAQ ExchangeMarket Cap$27.82M$22.82B$24.28B$8.32BDividend YieldN/A13.62%2.80%4.02%P/E Ratio-1.2214.8943.2619.25Price / Sales0.333.902,346.1094.10Price / Cash1.099.0234.6134.64Price / Book0.822.656.424.46Net Income$20.62M$1.01B$735.89M$247.07M7 Day Performance10.40%-1.47%1.67%3.06%1 Month Performance9.52%-0.20%49,593.10%-2.85%1 Year Performance-66.34%5.35%52,548.48%4.64% SurgePays Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SURGSurgePays2.2609 of 5 stars$1.38+5.3%$8.50+515.9%-71.2%$27.82M$83.60M-1.2240Earnings ReportNews CoverageHigh Trading VolumeTELATELA Bio3.0381 of 5 stars$2.43+3.4%$9.25+280.7%-75.6%$95.71M$68.65M-1.44120Earnings ReportHYPRHyperfine3.2903 of 5 stars$1.28+39.3%$1.60+25.0%-17.8%$93.38M$13.26M-2.25190Analyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeZYXIZynex3.2887 of 5 stars$2.90-2.4%$10.25+253.4%-79.7%$92.55M$192.35M19.331,100News CoverageHigh Trading VolumeLUCDLucid Diagnostics2.2024 of 5 stars$1.47+5.8%$3.63+146.6%+37.6%$87.23M$4.19M-1.2970Analyst ForecastNews CoverageGap UpHigh Trading VolumeFONRFONAR2.319 of 5 stars$13.98+1.2%N/A-38.4%$86.72M$101.57M12.16480Positive NewsEDAPEdap Tms1.8988 of 5 stars$2.29+1.8%$19.00+729.7%-70.7%$84.97M$63.41M-3.52230Upcoming EarningsGap DownICCMIceCure Medical2.749 of 5 stars$1.52+7.0%$2.70+77.6%+8.4%$84.36M$3.67M-5.2460News CoverageGap UpNSPRInspireMD2.3186 of 5 stars$2.80flat$4.75+69.6%+15.6%$83.13M$7.01M-3.7350SRTSSensus Healthcare2.8394 of 5 stars$4.86+4.5%$13.00+167.5%+27.6%$80.17M$41.81M12.1540NTRBNutriband2.9759 of 5 stars$6.57+6.0%$13.00+97.9%+153.0%$72.97M$2.02M-9.2510Positive News Remove Ads Related Companies and Tools Related Companies TELA Bio Competitors Hyperfine Competitors Zynex Competitors Lucid Diagnostics Competitors FONAR Competitors Edap Tms Competitors IceCure Medical Competitors InspireMD Competitors Sensus Healthcare Competitors Nutriband Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SURG) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SurgePays, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SurgePays With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SURG Stock Free SURG Stock Alerts